摘要
将78例原发性肺癌患者分为温补组(治疗组)和非温补组(对照组)进行临床观察研究。结果治疗组47例,有效29例,无效18例,有效率为61.7％;对照组31例,有效8例,无效23例,有效率为25.8％。两组疗效经统计学处理(p<0.05),差异显著。实践证明,对中晚期肺癌证属肺肾、肺脾阳气虚者,通过温补肺肾、肺脾,确有增强体质,抗御病邪,稳定病情,延长生存期的效果。
A comparative study of 78 patients with primary bronchogeniccarcinoma was reported. These patients were randomly divided intotwo groups: warm-invigorating group (47 cases) and non-warm-in-vigorating gronp(31 cases), In the warm-invigorating group, 29 pa-tients showed effective response to treatment of either warming thelung and spleen or warming the lung and kidney. 18 patiens failedto respond. the response rate was 61. 7%; whereas in the non-warm-invigorating group, 8 patients showed effective response toroutine treatment. 23 patients failed to respond, so the response ratewas 25. 80%. There was statistical significance of difference betweenthem(p<0. 05). According to our experience. for patients in medialor late stages of bronchogenic carcinoma, the warm-invigoratingtherapy is truly conducive to strengthening patients bodily resistanceto evil factors. stabilizing disease condition and prolonging life.
出处
《中国中医急症》
1993年第4期155-157,共3页
Journal of Emergency in Traditional Chinese Medicine
关键词
肺肿瘤
癌
温补脾肾
疗效
Primary bronchogenic carcinoma
Warm-in-vigorating therapy
